early prostate cancer recurrence

Blood test spots failing prostate cancer treatment within 6-12 weeks, study finds — Photo by www.kaboompics.com on Pexels

58% Miss Residual Prostate Cancer: PSA vs Biomarkers

58% Miss Residual Prostate Cancer: PSA vs Biomarkers Nearly 58% of standard PSA tests miss residual prostate cancer activity that appears within 6-12 weeks after definitive treatment. This hidden relapse can turn a curable case into a palliative one, making early biomarker monitoring essential. Medical Disclaimer: This article is for